Diagnoses 🩺📋
These are the diagnoses I have, some cogenital, others new since Long Covid. Pulled from my own records across my primary care health system, a tertiary referral center, another regional health system, an ENT specialty clinic, a neuro-optometry clinic, and a general optometry clinic — then deduped and grouped by system.
This isn’t every label that’s ever been applied to me. It’s the active problem list as of the most recent record sync, plus a small Inactive/Resolved section for context. Some entries (especially the older “anxiety” ones) predate the COVID infection in November of 2024; most of the more recent neurological, eye, and ENT entries do not.
This is not medical advice, this is a collection of my diagnostic records.
Neurological & Cognitive
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Progressive mild cognitive impairment | G31.84 | 2026-04-29 | Documented by neurology as significantly affecting daily functioning. MoCA 25/30. Etiology unclear; differential includes neurodegenerative, post-COVID sequelae, medications, anxiety/depression, and autoimmune/metabolic causes. P-tau 217, DaTscan, and repeat neuropsych testing ordered |
| Chronic gait instability | R26.81 | 2026-04-29 | Episodes of leg weakness and falls; multifactorial, attributed to vestibular dysfunction and deconditioning. Cane used for safety |
| Distal small fiber neuropathy — suspected | Pending | 2026-04-08 | Thermoregulatory sweat test (Mayo) showed anhidrosis of toes and hypohidrosis of feet. Medication confounders (meclizine, duloxetine, cetirizine, mirtazapine, fexofenadine) cannot be excluded |
| Persistent postural-perceptual dizziness (PPPD) | H81.8X9 | | Chronic dizziness syndrome often triggered by acute vestibular events |
| Migraine with vertigo | G43.109 | | Vestibular migraine |
| Dizziness | R42 | 2026-05-01 | Added during the April–May 2026 ER cluster |
| Restless legs syndrome — chronic, refractory | G25.81 | 2026-02-02 | Pramipexole losing efficacy; gabapentin and pregabalin previously caused edema and worsened tremors. Augmentation risk discussed; consider iron supplementation if ferritin low. Sleep medicine referral recommended |
| Attention and concentration deficit | R41.840 | 2026-02-12 | Post-viral cognitive change |
| ADD (attention deficit disorder) | F98.8 | 2025-02-11 | |
| Chronic neck pain | G89.29 | | |
Mental Health
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Anxiety disorder due to general medical condition with panic attack | F41.0 | 2026-04-25 | ICD F06.4 framing — the chart documents the anxiety as physiologically driven, not idiopathic |
| Major depressive disorder, recurrent episode, moderate | F33.1 | 2026-04-22 | Re-noted during the April 2026 ER visits |
| Generalized anxiety disorder | F41.1 | 2017-10-28 | Pre-existing |
| Adjustment disorder with mixed anxiety and depressed mood | F43.23 | 2017-12-22 | Pre-existing |
ENT & Vestibular
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Pulsatile tinnitus | H93.A9 | | Heart-beat-synchronized tinnitus |
| Hyperacusis, left ear | H93.232 | | Sound sensitivity |
| Mixed conductive and sensorineural hearing loss, left ear | H90.72 | | Right ear unaffected |
| Perforation of left tympanic membrane | H72.92 | | |
| Cochlear hydrops | H83.8X9 | 2026-03 | ENT attribution for vestibular and ear symptoms; treated with diuretic and betahistine. Referred to ENT for possible third-window evaluation |
| Perilymphatic fistula (PLF) | H83.1X2 | 2026-05 | Confirmed by ENT; surgical repair (exploratory tympanotomy, FlexHD tympanoplasty, round-window reinforcement, lysis of adhesions) performed May 2026. Improved hearing post-op but did not improve dizziness |
Vision & Eye
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Intermittent alternating esotropia | H50.32 | 2025-01-13 | Managed with prism correction; first diagnosed at neuro-optometric eval |
| Divergence insufficiency | H51.8A | 2025-01-13 | Eso at distance, exo at near |
| Vertical heterophoria | H50.53 | 2025-01-13 | Treated with vertical prism in glasses |
| Deficiency of saccadic eye movements | H55.81 | 2025-01-13 | Eye-movement deficit consistent with post-concussion / post-COVID patterns |
| Visual field defect, constriction OU | H53.483 | 2025-11-12 | Bilateral visual field constriction confirmed by automated perimetry |
| Abnormal oculomotor study | R94.113 | 2025-11-12 | Per sensorimotor examination at general optometry clinic |
| Esophoria, right eye | H50.51 | 2025-11-12 | |
| Hypermetropia (farsightedness), both eyes | H52.03 | 2025-01-13 | |
| Presbyopia | H52.4 | 2025-01-13 | |
| Posterior subcapsular polar cataract, right eye | H25.041 | 2025-11-12 | First flagged by general optometry clinic 2025-11-12; added to primary care problem list 2026-04-02 |
| Variable esodeviation with binocular diplopia | H53.2 | 2026-05-20 | Neuro-ophthalmology characterization of the alternating esotropia: alignment varies across exams and prism prescriptions; horizontal/diagonal diplopia worse at distance |
| Ocular myasthenia gravis — suspected, under workup | Pending | 2026-05-20 | Raised by neuro-ophthalmology on 2026-05-20 due to variable ocular alignment across exams; MG laboratory testing ordered. Medication trial may follow if labs negative (purely ocular MG has ~50% false-negative rate) |
Cardiovascular & Metabolic
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Metabolic syndrome | E88.810 | 2026-03-25 | Constellation: dyslipidemia + hyperglycemia tendency |
| Hyperlipidemia | E78.5 | 2024-02-09 | Pre-existing; on atorvastatin |
Musculoskeletal
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Cervical radiculopathy | M54.12 | 2026-02-24 | |
| Osteoarthritis of cervicothoracic spine | M47.813 | 2026-04-15 | |
| Spondylosis of cervical region without myelopathy or radiculopathy | M47.812 | 2025-06-13 | |
| Lumbar spina bifida without hydrocephalus | Q05.7 | 2025-01-13 | Congenital |
| Spina bifida occulta | Q76.0 | 2026-02-02 | Congenital |
| Cerebellar tonsillar ectopia | Pending | 2026-04-26 | Incidental MRI brain finding — does not meet criteria for Chiari malformation |
Other
| Diagnosis | ICD-10 | First noted | Notes |
|---|
| Other insomnia | G47.09 | 2026-04-25 | Added during the April–May 2026 ER cluster |
| Irritable bowel syndrome with diarrhea | K58.0 | 2023-11-09 | Pre-existing |
| Mild intermittent asthma | J45.20 | | Pre-existing; on Symbicort |
Inactive or Resolved (for context)
| Diagnosis | ICD-10 | Status | As of | Notes |
|---|
| Long COVID | U09.9 | Inactive (primary care) / Active (neuro-optometry, neurology) | 2025-07-10 | Primary care system marked Inactive 2025-07-10. Neuro-optometry has it documented Active across three visits (2025-01-13, 2025-05-01, 2025-08-01) and explicitly attributes binocular vision dysfunction to it. Neurology (2026-04-29) explicitly carries 'Chronic post-COVID syndrome' as an active assessment — referred to Mayo Long COVID clinic urgent waitlist and HCMC autonomic lab |
| Vestibular dysfunction | H81.90 | Inactive (primary care) / Active (neurology) | 2025-07-10 | Primary care marked Inactive 2025-07-10; neurology clinic still has it on the active problem list as of 2026-05-20. Reframed under PPPD on the primary care side |
| Balance problem | R26.89 | Inactive | 2025-07-10 | |
| Psychophysiologic insomnia | F51.04 | Resolved | 2026-02-11 | |
| Other somatoform disorders | F45.8 | Resolved | 2026-02-11 | |
| Mechanical low back pain | M54.59 | Resolved (primary care) / Active (neurology) | 2026-02-11 | Primary care marked Resolved 2026-02-11; neurology still has it on the active problem list as of 2026-05-20 |
Workup completed
Tests and imaging that have been performed during this workup — what's been ruled out or characterized so far. Mostly unrevealing, which is itself part of the Long Covid story.
| Test / Study | Date | Result |
|---|
| MRI brain (with and without contrast) | 2026-04-26 | Stable. No demyelinating disease. Minor nonspecific T2/FLAIR hyperintensities, unchanged from prior. Mild cerebellar tonsillar ectopia not meeting criteria for Chiari malformation. |
| CT head | 2026-04-06 | No findings on either side to explain inner-ear or disequilibrium symptoms. No 3rd-window phenomenon or bony dehiscence. |
| CT temporal bones (SCDS protocol with Stenvers/Pöschl reformats) | 2026-03-10 | Normal temporal bones bilaterally; left tympanostomy tube in place. (Sensitive to dehiscence, less so to near-dehiscence.) |
| MRA head | 2025-04-25 | No aneurysm, no high-flow vascular malformation, no high-grade stenosis. |
| MRV head | 2025-04-25 | No dural venous sinus thrombosis. |
| MRI cervical spine | 2026-02-04 | Multilevel degenerative changes. Severe right C5-C6 neural foraminal stenosis, moderate right C4-C5. No high-grade spinal canal stenosis. |
| MRI lumbar spine | 2024-08-12 | Multilevel degenerative changes without high-grade canal or foraminal stenosis. |
| EMG, bilateral upper extremities | 2025-09-12 | Normal. No motor radiculopathy, no median/ulnar/radial mononeuropathy. |
| EMG (fasciculation workup) | 2024-06-20 | Benign-appearing fasciculation potentials in calves; consistent with benign fasciculation syndrome. |
| Lumbar puncture | 2025-06-10 | Normal opening pressure. Oligoclonal bands negative, IgG index 0.52, normal protein/glucose, Borrelia negative, VDRL non-reactive. |
| Autoimmune / paraneoplastic antibody panel | 2025–2026 | All antibodies negative — Anti-Hu, Anti-Ri, NMDA-R, GAD65, Aquaporin 4, VGCC, CASPR2, LGI1, GABA-B-R, IgLON5, and others. |
| Rheumatologic / connective-tissue workup | 2026-01-16 | ANCA, MPO, SSA/SSB, C3, C4, CRP, ESR, RF, cryoglobulin — all within normal limits or negative. |
| Exercise stress echocardiogram | 2026-04-06 | Negative for myocardial ischemia. EF 61% rest → 71% peak stress. Normal LV filling pressure at rest and with exercise. 10.9 METS, 90% age-predicted max HR. |
| Holter monitor (24 h) | 2026-04-07 | Sinus rhythm. HR 45–122, average 71. Two patient-triggered events (palpitations, dizziness) showed sinus rhythm with no ectopy. |
| 12-lead EKG | 2026-04-06 | Normal sinus rhythm. Normal ECG. |
| Thermoregulatory sweat test | 2026-04-08 | Anhidrosis of toes, hypohidrosis of feet — could suggest distal small fiber neuropathy. Medication effects (meclizine, duloxetine, cetirizine, mirtazapine, fexofenadine) cannot be excluded. |
A note on “Long COVID, Inactive”
You’ll see U09.9 Long COVID listed under Inactive (primary care system) / Active (neuro-optometry clinic). That’s not because Long COVID resolved — my neuro-optometry clinic has documented it as active across three visits (1/13/2025, 5/1/2025, 8/1/2025) and explicitly attributes my binocular vision dysfunction to it. Different providers, same patient, two different “is it still happening?” answers.
